Literature DB >> 16251745

Isolation and culture of term human trophoblast cells.

Margaret G Petroff1, Teresa A Phillips, Hakhyun Ka, Judith L Pace, Joan S Hunt.   

Abstract

Experimentation with most human cell types is restricted to the use of cell lines, and this limits our ability to extrapolate interpretations to the in vivo condition. However, in studying human trophoblast cells, we have a unique opportunity to obtain large quantities of readily available human tissue. In this chapter, we outline the methodology for purification of human trophoblast cells from term placentas. The procedures are based on enzymatic dissociation of villous placental tissue, followed by gradient centrifugation and immunomagnetic bead purification. Purity may be assessed by immunocytochemistry or flow cytometry using a number of markers to identify both cytotrophoblast cells and cellular contaminants. The resulting cytotrophoblast cell populations have excellent viability and purity, and may be subjected to long-term culture.

Entities:  

Mesh:

Year:  2006        PMID: 16251745     DOI: 10.1385/1-59259-983-4:201

Source DB:  PubMed          Journal:  Methods Mol Med        ISSN: 1543-1894


  43 in total

1.  Minor histocompatibility antigens are expressed in syncytiotrophoblast and trophoblast debris: implications for maternal alloreactivity to the fetus.

Authors:  Olivia J Holland; Caitlin Linscheid; Herbert C Hodes; Traci L Nauser; Melissa Gilliam; Peter Stone; Larry W Chamley; Margaret G Petroff
Journal:  Am J Pathol       Date:  2011-11-08       Impact factor: 4.307

2.  Wide-ranging DNA methylation differences of primary trophoblast cell populations and derived cell lines: implications and opportunities for understanding trophoblast function.

Authors:  Boris Novakovic; Lavinia Gordon; Nicholas C Wong; Ashley Moffett; Ursula Manuelpillai; Jeffrey M Craig; Andrew Sharkey; Richard Saffery
Journal:  Mol Hum Reprod       Date:  2011-02-02       Impact factor: 4.025

3.  Isolation and characterization of trophoblasts from enzymatic explants of human term placenta.

Authors:  Tamara D Kolokoltsova; Irina N Saburina; Irina M Zurina; Anastasia A Gorkun; Nastasia V Kosheleva; Vadim S Repin; Rimma A Poltavtseva; Gennady T Sukhikh
Journal:  Hum Cell       Date:  2017-06-13       Impact factor: 4.174

4.  Regulation of human placental drug transporters in HCV infection and their influence on direct acting antiviral medications.

Authors:  Emily Pfeifer; Jessica Parrott; Gene T Lee; Ericka Domalakes; Helen Zhou; Lily He; Clifford W Mason
Journal:  Placenta       Date:  2018-07-10       Impact factor: 3.481

5.  Low-affinity uptake of the fluorescent organic cation 4-(4-(dimethylamino)styryl)-N-methylpyridinium iodide (4-Di-1-ASP) in BeWo cells.

Authors:  Erik Rytting; Jordan Bryan; Marylee Southard; Kenneth L Audus
Journal:  Biochem Pharmacol       Date:  2006-12-01       Impact factor: 5.858

6.  Progesterone-induced blocking factor differentially regulates trophoblast and tumor invasion by altering matrix metalloproteinase activity.

Authors:  Melinda Halasz; Beata Polgar; Gergely Berta; Livia Czimbalek; Julia Szekeres-Bartho
Journal:  Cell Mol Life Sci       Date:  2013-06-27       Impact factor: 9.261

7.  Regulation of iodide uptake in placental primary cultures.

Authors:  R Burns; C O'Herlihy; P P A Smyth
Journal:  Eur Thyroid J       Date:  2013-11-27

Review 8.  Hemochorial placentation: development, function, and adaptations.

Authors:  Michael J Soares; Kaela M Varberg; Khursheed Iqbal
Journal:  Biol Reprod       Date:  2018-07-01       Impact factor: 4.285

Review 9.  Placental control of drug delivery.

Authors:  Sanaalarab Al-Enazy; Shariq Ali; Norah Albekairi; Marwa El-Tawil; Erik Rytting
Journal:  Adv Drug Deliv Rev       Date:  2016-08-12       Impact factor: 15.470

10.  Schistosome egg antigens elicit a proinflammatory response by trophoblast cells of the human placenta.

Authors:  Emily A McDonald; Jonathan D Kurtis; Luz Acosta; Fusun Gundogan; Surendra Sharma; Sunthorn Pond-Tor; Hai-Wei Wu; Jennifer F Friedman
Journal:  Infect Immun       Date:  2012-12-17       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.